Victor Kotsev, Author at Labiotech.eu

About

Victor Kotsev is a reporter-at-large. He does all things business, technology, and international politics, with a special focus on health and biotech. He has spent most of the 2010s covering the Balkans and the Middle East for the likes of USA Today, Globe and Mail, and Fast Company, primarily out of Istanbul.

Articles by Victor Kotsev

News and Trends 14 Jul 2022

Agomab bags $114 million in thriving regenerative medicine sector

The Belgian company Agomab Therapeutics has topped up its Series B round by $40.5 million to hit $114 million. This Pfizer-led financing round extension is just the latest sign that…

July 14, 2022 - 3 minutesmins - By Victor Kotsev

stephanie bewick destiny pharma chief business officer

Expert Advice 2 May 2022

Chief Business Officers: Shedding Light on Biotech’s Dealmakers

In addition to helping patients, biotech companies need to focus on the commercial potential of their work. Stephanie Bewick at Destiny Pharma outlines her experiences of how a Chief Business…

May 2, 2022 - 5 minutesmins - By Victor Kotsev

News and Trends 11 Mar 2022

Microbiome Space in Spotlight as Microbiotica Sets Funding Record

Competition is heating up in the microbiome niche as UK-based Microbiotica raised €60M (£50M) in a Series B round to advance two candidates designed to treat cancer and ulcerative colitis.…

March 11, 2022 - 3 minutesmins - By Victor Kotsev

News and Trends 8 Feb 2022

Reforms of EU Clinical Trial Regulations Bring Cautious Optimism

The EU’s clinical trial regulations received a major overhaul at the end of January 2022 to make trials easier to run across EU member states. It may bring some short-term…

February 8, 2022 - 5 minutesmins - By Victor Kotsev

Kees Melief Chief Scientific Officer ISA Pharmaceuticals

Expert Advice 24 Jan 2022

Transitioning from Academia to Chief Scientific Officer in the Biotech Industry

Academics with a drive to turn their research into commercial products often end up in the position of Chief Scientific Officer at a biotech company. Kees Melief shares his own…

January 24, 2022 - 5 minutesmins - By Victor Kotsev

News and Trends 25 Nov 2021

Despite New Approvals, Covid-19 Treatments Lag Behind Vaccines

The EU recently added two drugs to its list of approved Covid-19 treatments. Yet with vaccines often in the spotlight, treatment options available to doctors remain few. Earlier this month,…

November 25, 2021 - 6 minutesmins - By Victor Kotsev

News and Trends 10 Nov 2021

Evotec IPO Hints At Stabilizing Investor Interest In Biotech Stocks

German life sciences heavyweight Evotec raised around €376M ($435M) in its US debut on the Nasdaq last week, fueling tentative hopes of renewed investor interest in biotech stocks after a…

November 10, 2021 - 4 minutesmins - By Victor Kotsev

Expert Advice 1 Nov 2021

“The Board of Directors Should Let the CEO Run the Company”

The relationship between the board and the CEO can be essential to the success of a life sciences company. Drawing from his experience at both sides, Alan Levy shares his…

November 1, 2021 - 5 minutesmins - By Victor Kotsev

News and Trends 26 Oct 2021

Valneva’s Inactivated Covid-19 Vaccine Aces Phase III Trial

Last week, the French vaccine maker Valneva announced promising phase III trial results of its inactivated Covid-19 vaccine: a well-established technology that could confer broader immunity to the virus than…

October 26, 2021 - 5 minutesmins - By Victor Kotsev

oxford nanopore technologies genomics sequencing

News and Trends 15 Oct 2021

Third-Generation DNA Sequencing Shines with Oxford Nanopore’s IPO

Oxford Nanopore Technologies, until recently one of very few unicorns in the European biotech industry, had a stellar IPO on the London Stock Exchange late last month. This is ushering…

October 15, 2021 - 5 minutesmins - By Victor Kotsev

Switzerland longevity geroscience foundation

News and Trends 11 Oct 2021

Longevity Foundation to Fund Geroscience Research with €860M

The newly-created Longevity Science Foundation aims to extend the human lifespan to more than 120 years by channeling over €860M ($1B) into early-stage geroscience research in the next decade. Experts…

October 11, 2021 - 5 minutesmins - By Victor Kotsev

News and Trends 4 Oct 2021

Non-Viral Gene Therapies Get €51M Boost, Though Challenges Remain

Although most gene therapy still relies on non-infectious viral vectors for delivery, a recent venture financing round for the Swiss company Anjarium Biosciences has shone the spotlight on alternative vectors,…

October 4, 2021 - 5 minutesmins - By Victor Kotsev

News and Trends 24 Sep 2021

Breath Testing To Be Tapped by UK Pioneer with €50M Fundraising

After years of under-fulfilled promise, breath tests for cancer, liver disease, and respiratory conditions appear to be taking off with UK biotech Owlstone Medical raking in almost €50M (£42M) in…

September 24, 2021 - 3 minutesmins - By Victor Kotsev

Expert Advice 20 Sep 2021

What Makes a Good Chief Financial Officer in the Biotech Industry?

A chief financial officer in the life sciences needs to develop their skills beyond technical expertise. Catherine Moukheibir shares her advice for CFOs in biotech drawing from her experience being…

September 20, 2021 - 8 minutesmins - By Victor Kotsev

Chikungunya vaccine clinical trial Valneva

News and Trends 19 Aug 2021

Chikungunya Vaccine First to Succeed in Phase III Trial

In a significant step in the fight against tropical disease, the mosquito-borne viral disease chikungunya may become preventable with a new vaccine candidate from French biotech Valneva that just passed…

August 19, 2021 - 3 minutesmins - By Victor Kotsev

News and Trends 3 Aug 2021

Oral and Nasal Covid-19 Vaccines Hit Clinical Testing

Oramed’s jab-free oral Covid-19 vaccine is one of many in the form of pills, powders, or sprays that may hit the market in the next few years, which could dramatically…

August 3, 2021 - 5 minutesmins - By Victor Kotsev

Expert Advice 2 Aug 2021

The Path to Becoming a Chief Medical Officer in the Biotech Industry

Life science researchers with an entrepreneurship inclination are often attracted to leadership positions with a focus on medical science. Daniel Chung shares his journey to becoming the Chief Medical Officer…

August 2, 2021 - 6 minutesmins - By Victor Kotsev

danish biotech neurodegenerative alzheimers 1

News and Trends 20 Jul 2021

Danish Dementia Startup Launches Amid Maturing Nordic Biotech Scene

Muna Therapeutics debuted with the Danish biotech sector’s biggest-ever Series A round earlier this month. This showcases the rapid growth taking place in the biotech industry in the Nordic region.…

July 20, 2021 - 4 minutesmins - By Victor Kotsev

News and Trends 14 Jul 2021

EMA Market Approval Rate for Small Biotechs Skyrocketed Last Year

The success rate for small biotechs applying for regulatory approval from the EMA has risen by over 100% since 2016, which analysts partly attribute to increased access to sophisticated technology…

July 14, 2021 - 3 minutesmins - By Victor Kotsev

News and Trends 30 Jun 2021

GSK Raises Eyebrows in Checkpoint Inhibitor Megadeal with iTeos

Analysts are abuzz over GSK’s co-development deal with immuno-oncology specialist iTeos Therapeutics earlier this month, wondering if it overpaid for the Belgian company’s next-generation checkpoint inhibitor. GSK’s oncology deal with…

June 30, 2021 - 5 minutesmins - By Victor Kotsev

Newsletter Signup

"*" indicates required fields

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

The Biotech Perspective 2023

View all companies A-Z

Find new scientific partnerships. Create a free IN-PART account

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inova, the leading platform for biopharma partnering